Cornerstone Investment Partners Q2 2026 Portfolio Activity: Heavy Technology Buys, Selective Sells

Cornerstone Investment Partners, a prominent investment firm focused on institutional strategies, has released its portfolio data for the second quarter ending June 30th, 2026. This filing provides valuable insight into their recent trading activity and allocation shifts.

The Q2 period was characterized by substantial buying in select Technology stocks, particularly KLA Corporation (KLAC). The firm increased its holdings of KLAC significantly this quarter, adding 524394 shares, representing a nearly 63% increase from the previous period. This large purchase pushed KLAC's portfolio allocation weight up to 6.13%. Other Technology names like Micron Technology (MU) and Applied Materials Inc. (AMAT) also saw changes, with the latter experiencing a significant reduction in its position.

In Financial Services, Cornerstone demonstrated active management through both buying and selling activities. They initiated a new position in Blackstone Inc. (BX), acquiring 428346 shares, or 100% of the current holdings, adding it at 1.68%. W. R. Berkley Corporation (WRB) also saw a substantial increase with an addition of 283642 shares, boosting its allocation to 3.15%. Conversely, they sold off shares in WRB (-26.95%) and reduced their stake in AMAT by over 34%.

The Healthcare sector witnessed notable additions as well. Stryker Corporation (SYK) was a significant new purchase for Cornerstone, acquiring all 181906 shares held currently at an allocation of 1.91%. Other buys in this space included IQVIA Holdings Inc. (IQV), Lexicon Pharmaceuticals (LXRX), and Cerus Corporation (CERS). In contrast, Thermo Fisher Scientific Inc. (TMO) was added to the portfolio with a smaller increase (+7182%) at 2.66%, while other Healthcare holdings like IQV saw a decrease (-32.95%).

Turning to new positions established during Q2, Cornerstone's data reveals several fresh additions to their investment thesis. These include Blackstone Inc., Stryker Corporation, and three other very small positions: Lexicon Pharmaceuticals (0.01%), Cerus Corporation (0.01%), and 3D Systems Corp. (0.01%). These new allocations signal potential interest in diversifying into areas like alternative asset management, medical technology, and healthcare/pharma services.

The most significant exit noted during the quarter was a sharp reduction (-53%) in holdings of Micron Technology. Cornerstone sold over 150,000 shares from their position. Other exits include IQVIA Holdings Inc. (IQV) and the closure of very small positions like those in LXRX and CERS.